Journals / Troia Tıp Dergisi / 2023 / Cilt: 4 - Sayı: 1

Frequency of anosmia within neurological symptoms in long/ post COVID and impact on quality of life

Long/post COVID’de anosminin nörolojik semptomlar içindeki sıklığı ve yaşam kalitesine etkisi

Pages
22–26
Publication Date
2023-01-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although anosmia is less important in neurological findings since it is not life-threatening, it continues in the long-COVID period and negatively affects the quality of life of patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Anosmia is one of the most common neurological symptoms of COVID-19, which causes deterioration in quality of life.
📊
Key Findings & Data:In this study, it was aimed to examine the frequency of long-term anosmia in and its effects on quality of life in patients with the COVID-19.
💡
Conclusion & Impact:Although anosmia is less important in neurological findings since it is not life-threatening, it continues in the long-COVID period and negatively affects the quality of life of patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:uzamış COVID-19 · anosmi · yaşam kalitesi

Abstract

Objectives: Anosmia is one of the most common neurological symptoms of COVID-19, which causes deterioration in quality of life. In this study, it was aimed to examine the frequency of long-term anosmia in and its effects on quality of life in patients with the COVID-19. Methods: A total of 266 (103 male, 163 female) patients aged 18 years and older, whose diagnosis was confirmed by PCR test, were included in the study. The Notthingham Health Profile (NHP) was used to measure quality of life. Results: Forty-six (17.3%) of the participants did not have any complaints. Anosmia was not present in 76 (34.5%) of 220 (82.7%) participants with complaints, was present only in acute disease in 111 (50.5%) and was seen to continue in the long-COVID-19 period in 33 (15%) participants. The NHP pain, physical activity, and energy subscale scores of those who reported experiencing anosmia were higher than those who did not. NHP pain and emotional reaction subscale scores of those who experienced anosmia during the acute illness period were lower than those who continued in the long-COVID-19 period. Conclusion: Prolonged anosmia has been detected at a high rate in COVID-19 patients. Although anosmia is less important in neurological findings since it is not life-threatening, it continues in the long-COVID period and negatively affects the quality of life of patients

Özet

Amaç: Anosmi, yaşam kalitesinde bozulmalara sebep olan ve Corona virüs hastalığı 2019 (COVID-19)’lu hastalarda görülen nörolojik semptomlar arasında en sık gözlenenlerden biridir. Bu çalışmada COVID-19 olan hastalarda uzun dönemde anosminin sıklığının ve yaşam kalitesi üzerindeki etkilerinin incelenmesi amaçlamıştır. Yöntem: Çalışmaya tanıları polimeraz zincir reaksiyonu (PCR) testi ile teyit edilmiş 18 yaş ve üzeri 266 (103’ü erkek, 163’ü kadın) hasta dahil edilmiştir. Yaşam kalitesini ölçmek için Notthingham Sağlık Profili (NSP) kullanılmıştır. Bulgular: Katılımcıların 46’sının (%17.3) hiçbir şikayetleri olmamıştır. Koku kaybı şikayeti 220 katılımcıdan (%82.7) 76’sında (%34.5) hiç olmamış, 111’inde (%50.5) sadece akut hastalıkta, 33’ünde (%15.0) ise uzamış COVID-19 döneminde de devam edecek şekilde görülmüştür. Koku kaybı yaşadığını bildirenlerin NSP ağrı, fiziksel aktivite ve enerji alt ölçek ortalama skorları koku kaybı yaşamamış olanlardan daha yüksektir. Akut hastalık döneminde koku kaybı yaşayıp takiplerinde iyileşenlerin NSP ağrı, duygusal reaksiyon alt ölçek ortalama skorları uzamış COVID-19 döneminde devam edenlerden daha düşüktür. Sonuç: COVID-19 hastalarında uzamış anosmi yüksek oranda saptanmıştır. Anosmi, yaşamı tehdit etmediği için nörolojik bulgular içinde daha az önemsenmiş olmasına rağmen uzamış COVID-19 döneminde de devam etmekte ve hastaların yaşam kalitesini olumsuz etkilemektedir.

🔖

Cite This Article

OCAK, Ö. (2023). Frequency of anosmia within neurological symptoms in long/ post COVID and impact on quality of life. Troia Tıp Dergisi, Cilt: 4 - Sayı: 1, 22–26. https://ajindex.com/articles/880235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020
  2. 11(7):995-998. 2.Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020
  3. Graham EL, Clark JR, Orban ZS, et al. Persistent neuro-logic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol 2021
  4. 8(5):1073-1085. 4. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with corona virus disease 2019 in Wuhan, China. JAMA Neurol 2020
  5. 77(6):683-690. 5. Spinato G, Fabrris C, Polesel J, et al. Alterations in smell or taste in mildy symptomatic outpatients with SARS -CoV -2 infection. Jama 2020
  6. 323(20):2089–2090. 6. Lechien JR, Chiesa -Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild -to –moderate forms of the corona virus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020
  7. 277(8):2251-2261. 7. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (UK) (NICE Guideline, No. 188). https://www.ncbi.nlm.nih.gov/books/NBK567261. (Son erişim tarihi: 30.08.2022) 8. Watson DLB, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: Anosmia, parosmia and the impact of long COVID-19. PLoS ONE 2021
  8. e0256998 9. Moraschini V, Reis D, Sacco R, Calasans‐Maia MD. Prevalence of anosmia and ageusia symptoms among long‐term effects of COVID‐19. Oral Dis 2021:10.1111/odi.13919. 10. Vaira LA, Salzano G, Bon SL, et al. Prevalence of persistent olfactory disorders in patients with COVID19: a psychophysical case-control study with 1-year follow-up. Otolaryngol Head Neck Surg 2022
  9. 167(1):183-186. 11. Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schöpf V, Mainland JD, Martens J, Ngai J, Duffy VB. Anosmia - a clinical review. Chem Senses 2017
  10. 42(7):513-523. 12. Philpott CM, Boak D. The impact of olfactory disorders in the United Kingdom. ChemSenses 2014
  11. 711–718 13. Liu DT, Prem B, Sharma G, Kaiser J, Besser G, Mueller CA. Depression symptoms and olfactory-related quality of life. Laryngoscope 2022
  12. 132(9):1829-1834. 14. Ferdenzi C, Bousquet C, Aguera PE, et al. Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observat